Glutamate Transporters: Expression and Function in Oligodendrocytes

被引:0
作者
Edna Suárez-Pozos
Elizabeth J. Thomason
Babette Fuss
机构
[1] Virginia Commonwealth University School of Medicine,Department of Anatomy and Neurobiology
来源
Neurochemical Research | 2020年 / 45卷
关键词
Glutamate; Glutamate transporter; Oligodendrocyte; Myelination; Multiple sclerosis; Neuropsychiatric disorders;
D O I
暂无
中图分类号
学科分类号
摘要
Glutamate, the main excitatory neurotransmitter of the vertebrate central nervous system (CNS), is well known as a regulator of neuronal plasticity and neurodevelopment. Such glutamate function is thought to be mediated primarily by signaling through glutamate receptors. Thus, it requires a tight regulation of extracellular glutamate levels and a fine-tuned homeostasis that, when dysregulated, has been associated with a wide range of central pathologies including neuropsychiatric, neurodevelopmental, and neurodegenerative disorders. In the mammalian CNS, extracellular glutamate levels are controlled by a family of sodium-dependent glutamate transporters belonging to the solute carrier family 1 (SLC1) that are also referred to as excitatory amino acid transporters (EAATs). The presumed main function of EAATs has been best described in the context of synaptic transmission where EAATs expressed by astrocytes and neurons effectively regulate extracellular glutamate levels so that synapses can function independently. There is, however, increasing evidence that EAATs are expressed by cells other than astrocytes and neurons, and that they exhibit functions beyond glutamate clearance. In this review, we will focus on the expression and functions of EAATs in the myelinating cells of the CNS, oligodendrocytes. More specifically, we will discuss potential roles of oligodendrocyte-expressed EAATs in contributing to extracellular glutamate homeostasis, and in regulating oligodendrocyte maturation and CNS myelination by exerting signaling functions that have traditionally been associated with glutamate receptors. In addition, we will provide some examples for how dysregulation of oligodendrocyte-expressed EAATs may be involved in the pathophysiology of neurologic diseases.
引用
收藏
页码:551 / 560
页数:9
相关论文
共 597 条
  • [1] Reiner A(2018)Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert Neuron 98 1080-1098
  • [2] Levitz J(2014)The role of glutamate and its receptors in the proliferation, migration, differentiation and survival of neural progenitor cells J Neural Transm (Vienna) 121 819-836
  • [3] Jansson LC(1995)Excitatory amino acids in health and disease J Am Geriatr Soc 43 1279-1289
  • [4] Akerman KE(2000)Glutamate as a neurotransmitter in the brain: review of physiology and pathology J Nutr 130 1007S-1015S
  • [5] Thomas RJ(2015)Overview of glutamatergic dysregulation in central pathologies Biomolecules 5 3112-3141
  • [6] Meldrum BS(1999)Tripartite synapses: glia, the unacknowledged partner Trends Neurosci 22 208-215
  • [7] Miladinovic T(2015)Glutamatergic transmission: a matter of three Neural Plast 2015 1-11
  • [8] Nashed M(2018)Molecular and cellular physiology of sodium-dependent glutamate transporters Brain Res Bull 136 3-16
  • [9] Singh G(2001)Glutamate uptake Prog Neurobiol 65 1-105
  • [10] Araque A(2004)The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects Pflügers Arch 447 469-479